Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization
NCT00479895
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Occlusion
Acute Coronary Syndrome
Interventions
DRUG:
Hemoglobin Based Oxygen Carrier-201 (HBOC-201, Hemopure)
Sponsor
Biopure Corporation